Related Experiment Video
Updated: Apr 18, 2026

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Enzyme engineering for optimizing biosynthesis of 2,4-dihydroxybutyric acid via the synthetic threose-dependent
Linxuan Wen1, Alrik Titze1, Christopher M Topham2
1Institute of Natural Materials Technology, TU Dresden, 01062 Dresden, Germany.
Abstract:
Ethylene glycol is a potential feedstock for next-generation biorefineries, as it can be derived from both plastic waste and carbon dioxide. The synthetic D-threose-dependent glycolaldehyde assimilation (STEGA) pathway, which is orthogonal to central metabolism of Escherichia coli, was recently constructed for the biosynthesis of the platform chemical 2,4-dihydroxybutyric acid (DHB) from ethylene glycol (EG). However, the performance of this pathway was limited by the low catalytic efficiency of key enzymes. Therefore, in the present study, structure-guided semi-rational engineering was employed to improve the activities of D-threose aldolase and D-threose dehydrogenase, originally provided by the fructose-6-phosphate aldolase L107Y:A129G mutant (Ec.FsaATA) from E. coli and the promiscuous D-threo-1-aldose dehydrogenase Pc.TadH from Paraburkholderia caryophylli, respectively. The substrate specificity of Ec.FsaATA was improved by replacing Arg134 by either isoleucine, methionine or valine which effectively eliminated activity of the mutant enzyme toward phosphorylated substrates while retaining homo-aldol condensation activity toward glycolaldehyde for D-threose formation. In-vivo implementation of the improved aldolase within the STEGA pathway reduced off-target glycolaldehyde flux, as demonstrated by 13C-carbon tracing experiments. Furthermore, the engineered Pc.TadH A24G:F58L double mutant exhibited an 11-fold increase in specificity constant (kcat/Km) on D-threose compared to the wild-type enzyme. As a consequence of these improvements, co-expression of both engineered enzymes in the STEGA pathway significantly enhanced EG-to-DHB bioconversion, achieving a 68% increase in final DHB titer (5.2 ± 0.11 mM) and a 23% improvement in carbon yield (0.16 ± 0.003 Cmol/Cmol).
Related Concept Videos
Bioreactor Controls-III
Production of Organic Acids
Upstream Processing
Biosynthesis in Bacteria
Production of Pharmaceuticals
Production of Antibiotics

